Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study
NCT01150136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2015-04-22
Summary
Cystic fibrosis (CF) is the most common lethal, inherited disorder among Caucasians. Choline is an essential vitamin and as a methyl donor is critically needed to support the normal metabolism. Our previous studies have demonstrated that children with CF have depleted levels of choline. The purpose of this study is to gather data on the status of choline and related metabolites in children with Cystic Fibrosis by age and gender. The hypothesis for this study is that in children with CF, deficiency of choline and related metabolites will increase with increasing age.
Conditions
Sponsors & Collaborators
-
Cystic Fibrosis Foundation
collaborator OTHER -
University of British Columbia
lead OTHER
Principal Investigators
-
Sheila M. Innis, Dr. · University of British Columbia
-
A. George F. Davidson, MD · University of British Columbia
Eligibility
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)
NCT00104494 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)
NCT06506773 ·Status: COMPLETED
-
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
NCT00530244 ·Status: COMPLETED ·Phase: NA
-
Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients
NCT02029521 ·Status: COMPLETED ·Phase: NA
-
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
NCT01031706 ·Status: COMPLETED ·Phase: NA
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis
NCT01605565 ·Status: COMPLETED ·Phase: NA
-
Zinc Status and Growth in Cystic Fibrosis
NCT04302428 ·Status: COMPLETED
-
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
NCT07223255 ·Status: RECRUITING ·Phase: NA
-
Baby Observational and Nutritional Study
NCT01424696 ·Status: COMPLETED
-
Statins To Treat Adult Cystic Fibrosis
NCT01092572 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Response to CFTR Modulators in CF Patients Under 18 Years
NCT04301856 ·Status: RECRUITING
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Effect of Glycine in Cystic Fibrosis
NCT01417481 ·Status: TERMINATED ·Phase: PHASE2
-
Cystic Fibrosis Related Bone Disease: the Role of CFTR
NCT01549314 ·Status: COMPLETED
-
Controlled Ventilation CT in CF Infants
NCT01200888 ·Status: TERMINATED
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
GERD in Children With Cystic Fibrosis
NCT06617013 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis
NCT01537614 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)
NCT00880100 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis
NCT04026360 ·Status: RECRUITING
-
Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis
NCT01783613 ·Status: COMPLETED ·Phase: NA
-
Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis
NCT00546663 ·Status: COMPLETED ·Phase: NA
-
Determinants of Early Cystic Fibrosis Lung Disease
NCT03579173 ·Status: COMPLETED
-
Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis
NCT04451213 ·Status: COMPLETED ·Phase: NA